The research so far indicates that exemestane appears to be safer than tamoxifen and raloxifene, which are associated with a higher risk of endometrial cancer and blood clots, as well as effects such as fatigue and depression. Because of these risks and effects, many women are reluctant to take tamoxifen and raloxifene. Although bone loss has been a concern with other aromatase inhibitors, exemestane did not produce any measurable changes in bone health. Its main side effects included aches, hot flashes, joint pain, and fatigue—but overall these effects were less problematic than those associated with tamoxifen. So overall, exemestane's safety profile appears to be very reassuring.
- Q What are the possible side effects of Keytruda?
- Q What should I know about Keytruda before taking it?
- Q What is Keytruda?
- Q How does the drug exemestane benefit women?
- Q What are aromatase inhibitors?
- Q Can Keytruda interact with other medications or foods?